Melita Kaltak was awarded for her poster by the Oligonucleotide Therapeutics Society

Melita Kaltak (ProQR Therapeutics NV) was selected as Poster Award Winner at the latest Oligonucleotide Therapeutics Society meeting for her work on an antisense oligonucleotide-mediated therapeutic approach for one of the most common Stargardt disease-causing variants in ABCA4. Very well done Melita!